Clinical Trials List
2020-09-20 - 2027-12-31
Phase II
Not yet recruiting1
Recruiting4
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/14
Investigators and Locations
Co-Principal Investigator
- Chao-Hua Chiu 無
- 蕭慈慧 無
- Yung-Hung Luo 無
- Heng-Sheng Chao 未分科
- Chi-Lu Chiang 無
- 趙恒勝 無
- Yuh-Min Chen 無
- Hsu-ching Huang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Cheng Chang 無
- 林定佑 無
- 邱立忠 無
- Chih-Hung Chen 未分科
- Ping-Chih Hsu 無
- Chih-Hung Chen 無
- Chih-Hsi Kuo 無
- 枋岳甫 無
- Chien-Ying Liu 無
- 柯皓文 無
- Shih-Hong Li 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
13 participants
-
Global
56 participants
